Bowles J, Mansoor M, Werb D, Kerr T, Bardwell G A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: motivations and initial impacts J Subst Use Addict Treat, 2024. PubMed
Fehr F, Lo LA, Nelson C, Nanson K, Diehl L, Nielson K, Reddon H, Walsh Z Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: obstacles and opportunities for improvement Int J Ment Health Nurs, 2024. PubMed
Robinson K, Laing A, Choi J, Richardson L Effect of modified income assistance payment schedules on substance use service access: evidence from an experimental study Int J Drug Policy, 2024. PubMed
Kennedy MC, Tobias S, Dong H, Buxton JA, Lysyshyn M, Tupper KW, Ti L Author reply to letter to the editor in response to "Fentanyl concentration in drug checking samples and risk of overdose death in Vancouver, Canada" Am J Prev Med, 2024. PubMed
Wood E, Bach P Fatal drug overdose risks of health care workers in the United States Ann Intern Med, 2024. PubMed
Laing A, Richardson L Fronts and friends: social contingencies in the management of drug debt Sociol Q, 2024. Link
Fleming T, Boyd J, Chayama KL, Knight KR, McNeil R Using alone at home: What's missing in housing-based responses to the overdose crisis? Harm Reduct J, 2024. PubMed
Cui Z, Karamouzian M, Law M, Hayashi K, Milloy MJ, Kerr T The impact of longitudinal substance use patterns on the risk of opioid agonist therapy discontinuation: a repeated measures latent class analysis Int J Ment Health Addict, 2024. PubMed
Reddon H, Socías ME, DeBeck K, Hayashi K, Walsh Z, Milloy MJ Cannabis use to manage stimulant cravings among people who use unregulated drugs Addict Behav, 2024. PubMed
Kennedy MC, Dong H, Tobias S, Buxton J, Lysyshyn M, Tupper K, Ti L Fentanyl concentration in drug checking samples and risk of overdose death in Vancouver, Canada Am J Prev Med, 2024. PubMed